State Street’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,760
| Closed | -$61.3K | – | 4392 |
|
|
2023
Q4 | $61.3K | Hold |
4,760
| – | – | ﹤0.01% | 4160 |
|
|
2023
Q3 | $30.5K | Hold |
4,760
| – | – | ﹤0.01% | 4374 |
|
|
2023
Q2 | $41.3K | Hold |
4,760
| – | – | ﹤0.01% | 4467 |
|
|
2023
Q1 | $68.5K | Hold |
4,760
| – | – | ﹤0.01% | 4423 |
|
|
2022
Q4 | $75.7K | Hold |
4,760
| – | – | ﹤0.01% | 4449 |
|
|
2022
Q3 | $76K | Hold |
4,760
| – | – | ﹤0.01% | 4553 |
|
|
2022
Q2 | $104K | Hold |
4,760
| – | – | ﹤0.01% | 4513 |
|
|
2022
Q1 | $127K | Buy |
4,760
+767
| +19% | +$20.5K | ﹤0.01% | 4564 |
|
|
2021
Q4 | $111K | Hold |
3,993
| – | – | ﹤0.01% | 4555 |
|
|
2021
Q3 | $180K | Hold |
3,993
| – | – | ﹤0.01% | 4390 |
|
|
2021
Q2 | $220K | Buy |
+3,993
| New | +$220K | ﹤0.01% | 4183 |
|